Roche Holding Ltd. (VTX:ROG) Given Consensus Recommendation of “Hold” by Brokerages
Roche Holding Ltd. (VTX:ROG) has been assigned an average recommendation of “Hold” from the fourteen research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is CHF 271.08.
Several brokerages have recently commented on ROG. Deutsche Bank AG set a CHF 273 target price on shares of Roche Holding and gave the company a “buy” rating in a report on Tuesday, June 6th. Barclays PLC set a CHF 320 target price on shares of Roche Holding and gave the company a “buy” rating in a report on Saturday, May 20th. Citigroup Inc. reiterated a “buy” rating on shares of Roche Holding in a report on Wednesday, July 5th. Kepler Capital Markets set a CHF 231 target price on shares of Roche Holding and gave the company a “neutral” rating in a report on Tuesday, June 6th. Finally, Sanford C. Bernstein set a CHF 284 target price on shares of Roche Holding and gave the company a “buy” rating in a report on Thursday, July 27th.
Shares of Roche Holding (VTX:ROG) opened at 248.00 on Friday. The firm has a market capitalization of CHK 211.61 billion and a price-to-earnings ratio of 20.95. The firm has a 50-day moving average of CHK 246.61 and a 200 day moving average of CHK 251.27. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00.
COPYRIGHT VIOLATION NOTICE: “Roche Holding Ltd. (VTX:ROG) Given Consensus Recommendation of “Hold” by Brokerages” was first published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.americanbankingnews.com/2017/08/05/roche-holding-ltd-vtxrog-given-consensus-recommendation-of-hold-by-brokerages.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.